Design of specific peptide inhibitors of phospholipase A2:: Structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS)

被引:37
|
作者
Chandra, V
Jasti, J
Kaur, P
Dey, S
Srinivasan, A
Betzel, C
Singh, TP [1 ]
机构
[1] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India
[2] DESY, UKE, Inst Med Biochem & Mol Biol, D-22603 Hamburg, Germany
关键词
D O I
10.1107/S0907444902013720
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Phospholipase A(2) (EC 3.1.1.4) is a key enzyme of the cascade mechanism involved in the production of proinflammatory compounds known as eicosanoids. The binding of phospholipase A2 to membrane surfaces and the hydrolysis of phospholipids are thought to involve the formation of a hydrophobic channel into which a single substrate molecule diffuses before cleavage. In order to regulate the production of proinflammatory compounds, a specific peptide inhibitor of PLA(2), Leu-Ala-Ile-Tyr-Ser, has been designed. Phospholipase A2 from Daboia russelli pulchella (DPLA(2)) and peptide LeuAla-Ile-Tyr-Ser (LAIYS) have been co-crystallized. The structure of the complex has been determined and refined to 2.0 Angstrom resolution. The structure contains two crystallographically independent molecules of DPLA2, with one molecule of peptide specifically bound to one of them. The overall conformations of the two molecules are essentially similar except in three regions; namely, the calcium-binding loop including Trp31 (residues 25-34), the beta-wing consisting of two antiparallel beta-strands (residues 74-85) and the C-terminal region (residues 119-133). Of these, the most striking difference pertains to the orientation of Trp31 in the two molecules. The conformation of Trp31 in molecule A was suitable to allow the binding of peptide LAIYS, while that in molecule B prevented the entry of the ligand into the hydrophobic channel. The structure of the complex clearly showed that the OH group of Tyr of the inhibitor formed hydrogen bonds with both His48 N-delta1 and Asp49 O-delta1, while (OH)-H-gamma of Ser was involved in a hydrogen bond with Trp31. Other peptide backbone atoms interact with protein through water molecules, while Leu, Ala and Ile form strong hydrophobic interactions with the residues of the hydrophobic channel.
引用
收藏
页码:1813 / 1819
页数:7
相关论文
共 18 条
  • [1] Crystal structure of the complex of group IPLA2 with a group II-specific peptide Leu-Ala-Ile-Tyr-Ser (LAIYS) at 2.6Å resolution
    Singh, RK
    Singh, N
    Jabeen, T
    Sharma, S
    Dey, S
    Singh, TP
    JOURNAL OF DRUG TARGETING, 2005, 13 (06) : 367 - 374
  • [2] Design of specific peptide inhibitors for group I phospholipase A2:: Structure of a complex formed between phospholipase A2 from Naja naja sagittifera (Group I) and a designed peptide inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1.9 Å resolution reveals unique features
    Singh, RK
    Vikram, P
    Makker, J
    Jabeen, T
    Sharma, S
    Dey, S
    Kaur, P
    Srinivasan, A
    Singh, TP
    BIOCHEMISTRY, 2003, 42 (40) : 11701 - 11706
  • [3] Crystal structure of a complex formed between a snake venom phospholipase A2 and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution
    Chandra, V
    Jasti, J
    Kaur, P
    Dey, S
    Perbandt, M
    Srinivasan, A
    Betzel, C
    Singh, TP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) : 41079 - 41085
  • [4] Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy
    Wang, Peng
    Li, Yongtao
    Shao, Qiuping
    Zhou, Wenqin
    Wang, Kuifeng
    JOURNAL OF DRUG TARGETING, 2015, 23 (02) : 140 - 146
  • [5] Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2:: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 Å resolution
    Singh, N
    Jabeen, T
    Sharma, S
    Somvanshi, RK
    Dey, S
    Srinivasan, A
    Singh, TP
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2006, 62 : 410 - 416
  • [6] A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition
    Church, WB
    Inglis, AS
    Tseng, A
    Duell, R
    Lei, PW
    Bryant, KJ
    Scott, KF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) : 33156 - 33164
  • [7] First structural evidence of a specific inhibition of phospholipase A2 by α-tocopherol (vitamin E) and its implications in inflammation:: Crystal structure of the complex formed between phospholipase A2 and α-tocopherol at 1.8 Å resolution
    Chandra, V
    Jasti, J
    Kaur, P
    Betzel, C
    Srinivasan, A
    Singh, TP
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 320 (02) : 215 - 222
  • [8] Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDs):: Crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 Å resolution
    Singh, N
    Jabeen, T
    Somvanshi, RK
    Sharma, S
    Dey, S
    Singh, TP
    BIOCHEMISTRY, 2004, 43 (46) : 14577 - 14583
  • [9] Aspirin induces its anti-inflammatory effects through its specific binding to phospholipase A2:: Crystal structure of the complex formed between phospholipase A2 and aspirin at 1.9Å resolution
    Singh, RK
    Ethayathulla, AS
    Jabeen, T
    Sharma, S
    Kaur, P
    Singh, TP
    JOURNAL OF DRUG TARGETING, 2005, 13 (02) : 113 - 119
  • [10] Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: Solution structure and molecular modeling
    Thwin, Mating Maung
    Satyanarayanajois, Seetharama D.
    Nagarajarao, Latha M.
    Sato, Kazuki
    Arjunan, Pachiappan
    Ramapatna, Satish L.
    Kumar, Prem V.
    Gopalakrishnakone, Ponnampalam
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) : 5938 - 5950